ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $52,000 | -53.6% | 11,814 | -56.5% | 0.02% | +5.9% |
| Q1 2021 | $112,000 | -37.1% | 27,169 | -39.1% | 0.02% | -32.0% |
| Q4 2020 | $178,000 | +23.6% | 44,604 | -16.2% | 0.02% | 0.0% |
| Q3 2020 | $144,000 | +12.5% | 53,255 | +14.8% | 0.02% | 0.0% |
| Q2 2020 | $128,000 | +37.6% | 46,374 | +134.6% | 0.02% | +78.6% |
| Q4 2019 | $93,000 | +40.9% | 19,771 | +0.0% | 0.01% | -6.7% |
| Q3 2019 | $66,000 | -2.9% | 19,769 | -3.8% | 0.02% | +15.4% |
| Q2 2019 | $68,000 | +119.4% | 20,543 | +100.1% | 0.01% | +62.5% |
| Q1 2019 | $31,000 | -86.6% | 10,267 | -88.0% | 0.01% | -84.6% |
| Q4 2018 | $232,000 | – | 85,281 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |